学術雑誌論文 血管炎症候群(<特集>血管炎症候群とアフェレシス)
Vasculitis Syndrome

今, 高之  ,  山路, 健  ,  Takayuki, Kon  ,  Ken, Yamaji  ,  順天堂大学医学部膠原病内科  ,  順天堂大学医学部膠原病内科  ,  Department of Rheumatology and Internal Medicine, Juntendo University School of Medicine  ,  Department of Rheumatology and Internal Medicine, Juntendo University School of Medicine

内容記述
Classification of vasculitis from CHCC (Chapel Hill Consensus Conference) 1994 was revised in 2012 based on its pathology and etiology. The presence of biologic agents changed treatment strategy for the category of autoimmune diseases, but this change is not applicable for every case because of economic problems and adverse effects of the agents. We must understand the mechanism of the each vasculitis case because apheresis treatment for vasculitis syndrome has only limited evidence. Therefore, the role of apheresis is significant as supportive or alternative therapy for vasculitis syndrome in the era of the biologic agents.
本文を読む

https://projects.repo.nii.ac.jp/?action=repository_action_common_download&item_id=152403&item_no=1&attribute_id=21&file_no=1

このアイテムのアクセス数:  回

その他の情報